Role of Litigation in Defining Drug Risks_JAMA / BMJ

Documents uncovered during the course of litigation shed light on real risks of drug-induced harm that would not otherwise be known.Below are excerpts from two timely articles that offer persuasive arguments backed by evidence demonstrating that litigation provides vital drug safety information that physicians and the public need to protect consumers from drug-induced hazards. Documents [...]

The Secret Eli Lilly Zyprexa Documents–A Case For CivilDisobedience

FindLaw columnist, Julie Hilden, a First Amendment lawyer, brings a fresh
perspective to the controversy surrounding the sealed Zyprexa documents.
In general, she notes, “companies’ overprotecting drug-related information
predictably harms patients. It also has other bad effects: Research is
unnecessarily duplicated at different companies, in a waste of time and
effort, and cruel experiments on animals are duplicated, too.”
She challenges [...]